We are live on ! Find out more
ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 44.72%
This Fund
S&P 500
This Quarter Est. Return
+25%
1 Year Est. Return
+44.72%
3 Year Est. Return
+299.95%
5 Year Est. Return
+628.83%
10 Year Est. Return
–
AUM
$55.8M
AUM Growth
+$9.14M
Cap. Flow
+$1.17M
Cap. Flow %
2.09%
Top 10 Hldgs %
49.65%
Holding
44
New
22
Increased
4
Reduced
7
Closed
11

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$4.32M
2
GH icon
Guardant Health
GH
+$2.54M
3
VTRS icon
Viatris
VTRS
+$2.47M
4
CNC icon
Centene
CNC
+$2.41M
5
UNH icon
UnitedHealth
UNH
+$1.68M

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.64M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.78M
3
INSM icon
Insmed
INSM
+$2.78M
4
PTCT icon
PTC Therapeutics
PTCT
+$2.76M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$2.73M

Sector Composition

Rank Sector Weight
1 Healthcare 83.32%
2 Financials 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NCNA
26
NuCana
NCNA
$6.12M
$975K 1.75%
32
-1
-3% -$33.9K
FOLD
27
DELISTED
Amicus Therapeutics
FOLD
$962K 1.72%
+98,718
New +$904K
ASND icon
28
Ascendis Pharma A/S
ASND
$16.8B
$911K 1.63%
+6,547
New +$727K
CYTK icon
29
Cytokinetics
CYTK
$10.4B
$904K 1.62%
+85,172
New +$875K
MRTX
30
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$896K 1.61%
+6,950
New +$670K
VAR
31
DELISTED
Varian Medical Systems, Inc.
VAR
$843K 1.51%
+5,934
New +$757K
MRNS
32
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$766K 1.37%
+88,713
New +$498K
APLS
33
DELISTED
Apellis Pharmaceuticals
APLS
$655K 1.17%
+21,380
New +$592K
AMRN
34
Amarin Corp
AMRN
$303M
– –
-5,225
Closed -$1.58M
CRSP icon
35
CRISPR Therapeutics
CRSP
$5.17B
– –
-37,141
Closed -$1.52M
DXCM icon
36
DexCom
DXCM
$32B
– –
-59,080
Closed -$2.2M
HRTX icon
37
Heron Therapeutics
HRTX
$92.9M
– –
-39,273
Closed -$727K
NTRA icon
38
Natera
NTRA
$46.4B
– –
-63,112
Closed -$2.07M
PEN icon
39
Penumbra
PEN
$12.8B
– –
-2,700
Closed -$363K
VRCA icon
40
Verrica Pharmaceuticals
VRCA
$87.3M
– –
-7,430
Closed -$1.1M
GBT
41
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-75,011
Closed -$3.64M
ATRS
42
DELISTED
Antares Pharma, Inc.
ATRS
– –
-377,399
Closed -$1.26M
XLRN
43
DELISTED
Acceleron Pharma
XLRN
– –
-47,453
Closed -$1.88M
GWPH
44
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-23,729
Closed -$2.73M
1
2

Similar funds

FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
NM
Nokota Management New York $165M AUM

Asymmetry Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Asymmetry Capital Management held 44 positions worth $55.8M, up 20% from $46.7M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Asymmetry Capital Management's Q4 2019 filing shows 22 new, 4 increased, 7 reduced and 11 closed positions. Its largest new stake was Baxter International: 52,192 shares worth $4.36M. The largest sale was Global Blood Therapeutics, Inc., an estimated $3.64M.

By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 91% a quarter earlier, followed by Financials.

  • Asymmetry Capital Management's largest Q4 2019 buy was Baxter International: 52,192 shares worth $4.36M.
  • Asymmetry Capital Management added most to Tandem Diabetes Care in Q4 2019, an estimated $1.51M increase.
  • Asymmetry Capital Management's biggest Q4 2019 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $2.78M.
  • Asymmetry Capital Management fully exited Global Blood Therapeutics, Inc. in Q4 2019, selling an estimated $3.64M.
  • Asymmetry Capital Management's ten largest holdings make up 50% of its $55.8M portfolio in Q4 2019.
  • Asymmetry Capital Management opened 22 new positions and closed 11 in Q4 2019.
  • Asymmetry Capital Management's portfolio value rose 20% quarter-over-quarter to $55.8M.

Based on Asymmetry Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.